SCIACCA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 4.434
EU - Europa 2.447
AS - Asia 2.072
SA - Sud America 397
AF - Africa 252
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 9.614
Nazione #
US - Stati Uniti d'America 4.227
SG - Singapore 1.013
CN - Cina 796
IT - Italia 748
IE - Irlanda 575
UA - Ucraina 454
BR - Brasile 372
DE - Germania 201
CA - Canada 186
CI - Costa d'Avorio 182
RU - Federazione Russa 149
SE - Svezia 79
KR - Corea 62
IN - India 54
GB - Regno Unito 40
SN - Senegal 39
FR - Francia 30
FI - Finlandia 27
VN - Vietnam 26
BE - Belgio 23
CH - Svizzera 21
CZ - Repubblica Ceca 21
IR - Iran 20
TR - Turchia 20
AT - Austria 18
UZ - Uzbekistan 17
PL - Polonia 16
NL - Olanda 13
AR - Argentina 10
GR - Grecia 10
NG - Nigeria 10
IQ - Iraq 9
ES - Italia 8
JP - Giappone 8
MX - Messico 8
BD - Bangladesh 7
EU - Europa 7
LB - Libano 7
MA - Marocco 7
ZA - Sudafrica 7
AU - Australia 5
BG - Bulgaria 5
HK - Hong Kong 5
AE - Emirati Arabi Uniti 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
CO - Colombia 3
JM - Giamaica 3
JO - Giordania 3
LT - Lituania 3
NO - Norvegia 3
PK - Pakistan 3
SA - Arabia Saudita 3
BH - Bahrain 2
EC - Ecuador 2
EG - Egitto 2
HN - Honduras 2
IL - Israele 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BB - Barbados 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
KE - Kenya 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
Totale 9.614
Città #
Santa Clara 815
Singapore 604
Dublin 563
Jacksonville 524
Chandler 484
Catania 273
Chicago 264
Boardman 251
Abidjan 182
Nanjing 160
Cambridge 159
Lawrence 156
Andover 155
Hefei 150
Toronto 138
Ashburn 108
Beijing 99
Des Moines 99
Wilmington 82
Bremen 78
San Mateo 67
Civitanova Marche 65
Seoul 62
Nanchang 55
Grafing 52
Hebei 46
Munich 45
Shenyang 45
Changsha 40
Council Bluffs 39
Dakar 39
Saint Petersburg 39
São Paulo 33
Ottawa 31
Los Angeles 30
Quintano 30
Tianjin 30
The Dalles 28
Jiaxing 27
Kochi 27
Columbus 26
Brussels 23
Rome 22
Milan 18
Ardabil 17
Palermo 17
New York 16
Brno 15
Moscow 15
Ann Arbor 14
Falls Church 14
Seattle 14
Belo Horizonte 13
Brooklyn 12
Dong Ket 12
Norwalk 12
Lappeenranta 11
Pune 11
Warsaw 11
Washington 11
Abuja 10
San Francisco 10
Turku 10
Campinas 9
Gravina di Catania 9
Guangzhou 9
Izmir 9
Portici 9
Bronte 8
Dallas 8
Messina 8
Montreal 8
Tokyo 8
Giarre 7
Jinan 7
Leawood 7
Porto Alegre 7
Augusta 6
Carrara 6
Den Haag 6
Helsinki 6
Houston 6
Kunming 6
Liberty Lake 6
Mascalucia 6
Phoenix 6
Pozzallo 6
Tashkent 6
Turin 6
Vienna 6
Amsterdam 5
Hangzhou 5
Hanoi 5
Hong Kong 5
Pescara 5
Rio de Janeiro 5
Stockholm 5
Taizhou 5
Tappahannock 5
Zhengzhou 5
Totale 6.749
Nome #
La stimolazione con insulina o IGF-II delle isoforme A e B del recettore dell’insulina causa differenti effetti biologici in presenza di IRS-3 172
Body mass index is related to short term retinal worsening in type 2 diabetes patients treated with anticancer drugs 105
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 100
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels 93
Different Effects of the Insulin Receptor Isoforms on 32D Cell Growth and Differentiation 92
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 91
Efficacy of real-time glucose continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial 90
Combined use of sonographic and elastosonographic parameters can improve the diagnostic accuracy in thyroid nodules at risk of malignancy at cytological examination 88
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes 87
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 86
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved 84
Adipose tissue, obesity and adiponectin: Role in endocrine cancer risk 83
Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience 82
Insulin receptor isoforms differently regulate cell proliferation and apoptosis in the ligand‐occupied and unoccupied state 81
Insulin receptor isoforms in physiology and disease: An updated view 81
Type 2 Diabetic patients with Graves' Disease have more frequent and severe Graves’ orbitopathy 76
Papillary Thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries 75
The IGF system in thyroid cancer:new concepts 75
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 74
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 74
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. 73
Impact of unhealthy childhood and unfavorable parents' characteristics on adiposity in schoolchildren 73
Analoghi dell’insulina in gravidanza: Sono utili? Sono sicuri? 72
The isoform A of the insulin receptor as a regulator of the IGF system 72
Comment on: Yang et al. (2010) Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254-1260 72
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression 72
Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review 71
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 71
ASPB(10) insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: Evidence for enhanced interactions with the insulin-like growth factor-I receptor 71
COVID-19 vaccination in pregnant and lactating diabetic women 71
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 70
Continuous subcutaneous insulin infusion (CSII) vs multiple daily insulin injections (MDI) in type 1 diabetes: effects on blood glucose variability 70
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 70
Type I insulin-like growth factor receptor function in breast cancer 69
Infusione sottocutanea continua di insulina (CSII) e terapia insulinica multi-iniettiva (MDI) con glargine in pazienti con diabete mellito tipo 1 68
ASPB10 insulin, a super analog of insulin, causes an increased mitogenic response and phenotypic changes in human breast epithelial cells 68
Insulin and its analogs:actions via insulin and IGF receptors 67
Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women 67
Screening e diagnosi di diabete gestazionale 67
Insulin receptor isoforms in cancer 67
Associazione tra alterata tolleranza ai carboidrati e sindrome metabolica in gravidanza 66
Semaglutide: a game changer for metabolic diseases? 65
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism 65
Diabete e contraccezione 64
In IGF-I receptor-deficient leiomyosarcoma cells autcrine IGF-II induces cell cell invasion and protection from apoptosis via the insulin receptor isoform A 64
Differential Gene Expression Induced by Insulin-like Growth Factor-II through the Insulin Receptor Isoform A 63
Confronto tra infusione sottocutanea continua di insulina (CSII) e terapia multiiniettiva (MDI) nel DM1: 5 anni di follow-up 62
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling 62
Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts 62
Diabetes and Cancer 62
IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding 61
Diabetes and work: The need of a close collaboration between diabetologist and occupational physician 61
Studies of the purified fetal insulin receptor (IR-A) reveal that it is an IGF-II receptor 61
Signaling differences from the A and B isoforms of the insulin receptor in 32D cells in the presence or absence of IRS-1 60
Screening and diagnosis of GDM: a new approach 60
Obesity, insulin-resistance and cancer 60
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease 60
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells 60
Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling 59
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 59
Diabetes and cancer 59
Costruire un percorso assistenziale: investire per migliorare l'outcome e ridurre i costi 57
The role of insulin receptors and IGF-I receptors in cancer and other diseases 57
Gestational Diabetes Mellitus pregnancy by pregnancy: early, late and nonrecurrent GDM 56
Ruolo fisiologico della prima fase della secrezione insulinica 56
Progressione della retinopatia diabetica in soggetti in terapia insulinica con microinfusore o glargine: effetti del compenso e della variabilità glicemica 56
Signaling Differences from the A and B isoforms of the Insulin Receptor (IR) in 32D Cells in the Presence or Absence of IR Substrate-1 56
Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway 56
Good blood glucose control three years after giving birth in diabetic women treated with continuous subcutaneous insulin infusion (CSII) during pregnancy 56
Insulin receptors in breast cancer 56
Screening e diagnosi del diabete gestazionale. 56
Insulin-like growth factor II stimulates cell growth through the insulin receptor in brest cancer: a newly identified autocrine/paracrine loop 55
Insulin analogue effects through insulin receptor isoforms and IGF1R 55
Type 2 diabetes and cancer: problems and suggestions for best patient management 55
Insulin receptor isoforms are differently expressed during human osteoblastogenesis 54
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 54
Disordini del peso corporeo e del comportamento alimentare 54
Re:Insulin, Insulin-like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women 54
The novel loss of function Ile354Val mutation in PPARG causes familial partial lipodystrophy 54
Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study 54
Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta 54
Influence of Body Mass Index, Cancer Type and Treatment on Long-Term Metabolic and Liver Outcomes in Childhood Cancer Survivors 54
Analoghi dell’insulina e cancro 53
Monitoraggio in continuo del glucosio (CGM) in donne con diagnosi di diabete gestazionale suddivise in base al BMI pregravidico 53
Glicemia 1 h dopo carico orale di glucosio in donne normotolleranti con pregresso diabete gestazionale 53
Measurement of IGF-1 receptor content in tissues and cell lines by radioimmunoassay (RIA) and ELISA techniques. 53
Screening and diagnosis of GDM: a new approach 53
An observational study comparing Continous Subcutaneous Insulin Infusion (CSII) and insulin glargine in type 1 diabetes 53
Insulin degludec in the first trimester of pregnancy: Report of two cases 53
Risk for Coexistent Autoimmune Diseases in Familial and Sporadic Type 1 Diabetes is Related to Age at Diabetes Onset 53
Epigenetic mechanisms in type 2 diabetes retinopathy: A systematic review 53
Cancer drugs and diabetic retinopathy: a dangerous, underestimated association 52
Donna con alterazioni della glicemia e aborti ripetuti 52
I nuovi criteri diagnostici hanno modificato l’impatto del diabete gestazionale? 52
Insulin/IGFs receptors interactions with insulin and insulin analogues in pregnancy 52
Screening of postpartum diabetes in women with gestational diabetes: high-risk subgroups and areas for improvements-the STRONG observational study 52
Valori della glicemia a digiuno e HOMA-IR come semplici, indipendenti ed aggiuntivi fattori di rischio per diabete gestazionale e sindrome metabolica post-partum 51
Persistenza del buon compenso glicemico in donne con diabete pregravidico trattate con terapia insulinica sottocutanea continua (CSII) durante la gravidanza 51
Studio delle relazioni struttura/funzione della Tireoperossidasi (TPO) 51
Parametri predittivi per lo sviluppo del diabete mellito tipo 2 in donne con pregresso diabete gestazionale 50
Totale 6.584
Categoria #
all - tutte 39.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021873 0 68 110 11 217 26 110 8 115 5 161 42
2021/20221.164 142 164 10 18 187 9 174 42 97 0 45 276
2022/20231.776 175 47 20 235 154 328 1 293 413 21 56 33
2023/2024855 41 176 32 36 33 143 16 54 5 25 149 145
2024/20253.443 30 511 172 174 724 330 89 154 221 445 295 298
2025/2026615 441 174 0 0 0 0 0 0 0 0 0 0
Totale 9.899